Thor Medical ASA

Thor Medical ASA

4.36
NOK
-0.10
(-2.35%)
-4.01EPS
Mar 03Next Earn

Important Dates

Thor Medical ASA's next confirmed earnings release is scheduled for March 3, 2027.

Earnings Date3/3/2027

Share Statistics

As of June 30, 2022, Thor Medical ASA has 119.10M shares outstanding.

Shares Outstanding119.10M

Financial Position

As of June 30, 2022, Thor Medical ASA maintains a current ratio of 2.50, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is - -, indicating a certain level of leverage, while an interest coverage ratio of -1,369.64 demonstrates limited ability to service its debt obligations.

Current Ratio2.50
Quick Ratio2.32
Interest Coverage-1,369.64

Financial Efficiency

Over the twelve months ended June 30, 2022, Thor Medical ASA posted a negative return on equity (ROE) of -155.90, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -107.68, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 39.00, a quick read on workforce productivity versus industry peers.

Return on Equity (ROE)-155.90
Return on Assets (ROA)-107.68
Employee Count39.00

Taxes

NOK

Over the twelve months ended June 30, 2022, Thor Medical ASA recorded 1.16M in income tax expense. The company reported a pretax loss of -432.98M and -434.14M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax1.16M

Stock Price Statistics

NOK

As of the close on October 15, 2026, Thor Medical ASA's stock has gained approximately 25.11% over the past 52 weeks.

52-Week Price Change25.11%
50-Day Moving Average4.94

Income Statement

NOK

Over the twelve months ended June 30, 2022, Thor Medical ASA generated - - in revenue and converted that into -434.14M in net income, yielding earnings per share of -4.01. EBITDA reached -430.07M, while operating income came in at -440.49M.

Operating Income-440.49M
Pretax Income-432.98M
Net Income-434.14M
EBITDA-430.07M
EBIT-440.49M
Earnings Per Share (EPS)-4.01

Balance Sheet

NOK

As of June 30, 2022, Thor Medical ASA holds 287.44M in cash and equivalents against - - in total debt, resulting in a net debt position of -287.44M. Total book value stands at 182.55M, with working capital of 185.85M providing operational flexibility.

Cash & Cash Equivalents287.44M
Net Debt-287.44M
Equity (Book Value)182.55M
Book Value Per Share1.53
Working Capital185.85M

Cash Flow

NOK

Thor Medical ASA produced -393.65M in operating cash flow over the twelve months ended June 30, 2022. After subtracting -150,000.00 in capital expenditures, free cash flow totaled -393.80M - equivalent to -3.63 per share.

Operating Cash Flow-393.65M
Capital Expenditures-150,000.00
Free Cash Flow-393.80M
FCF Per Share-3.63

Stock Splits

Thor Medical ASA's most recent stock split took place on June 19, 2025.

Last Split Date6/19/2025